bioRxiv Science⌕ Search

Biology subjects

Verdes, J. M.

Publications and source records attributed to Verdes, J. M..

2 recordsLinked to original sources

Trypanosoma cruzi isolates naturally adapted to congenital transmission display a unique strategy of transplacental passage

Chagas disease is mainly transmitted by vertical transmission (VT) in non-endemic areas and in endemic areas where vector control programs have been successful. For the present study, we isolated natural strains vertically transmitted through three generations and proceeded to study their molecular mechanism of VT. No parasitemia was detected in immunocompetent mice, but they were able to induce an immune response and colonize different organs. VT experiments revealed that infection with the different strains did not affect mating, pregnancy or resorptions, but despiting low parasitemia, VT strains reached the placenta and resulted in higher vertical transmission rates than strains of either moderate or high virulence. While the virulent strain modulated more than 2500 placental genes, VT strains modulated 150, and none of the modulated genes is shared between them. VT strains downregulate genes associated with cell division and replication and upregulate immunomodulatory genes leading to anti-inflammatory responses and tolerance. The virulent strain stimulates a strong pro-inflammatory immune response, and this molecular footprint correlated with histopathological analyses. We herein describe a unique placental response regarding the passage of T cruzi VT isolates across the maternal-fetal interphase, challenging the current knowledge derived mainly from studies of laboratory-adapted or highly virulent strains.

microbiology↗

Ivermectin reduces coronavirus infection in vivo: a mouse experimental model

SARS-CoV2 is a single strand RNA virus member of the type 2 coronavirus family, responsible for causing COVID-19 disease in humans. The objective of this study was to test the ivermectin drug in a murine model of coronavirus infection using a type 2 family RNA coronavirus similar to SARS-CoV2, the mouse hepatitis virus (MHV). BALB/cJ female mice were infected with 6,000 PFU of MHV-A59 (Group Infected; n=20) and immediately treated with one single dose of 500 g/kg of ivermectin (Group Infected + IVM; n=20), or were not infected and treated with PBS (Control group; n=16). Five days after infection/treatment, mice were euthanized to obtain different tissues to check general health status and infection levels. Overall results demonstrated that viral infection induces the typical MHV disease in infected animals, with livers showing severe hepatocellular necrosis surrounded by a severe lymphoplasmacytic inflammatory infiltration associated with a high hepatic viral load (52,158 AU), while ivermectin administration showed a better health status with lower viral load (23,192 AU; p<0.05) and few livers with histopathological damage (p<0.05), not showing statistical differences with control mice (P=NS). Furthermore, serum transaminase levels (aspartate aminotransferase and alanine aminotransferase) were significantly lower in treated mice compared to infected animals. In conclusion, ivermectin seems to be effective to diminish MHV viral load and disease in mice, being a useful model for further understanding new therapies against coronavirus diseases.

pathology↗